Drug developers behind currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.

by Kate Yandell

Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.

by Kate Yandell

Experts discuss the value of cancer treatments in a climate of rising drug prices.

by Kevin McLaughlin

Some researchers believe that immunotherapy occasionally causes cancer to grow faster, a phenomenon dubbed hyper-progression.

by Kate Yandell

Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.

by Kevin McLaughlin

Jury awards damages to man who says Roundup caused his cancer, the FDA proposes national standards for breast density notifications, and a physician questions whether patients with impaired renal function should avoid contrast-enhanced scans.

by Marci A. Landsmann

Policy Matters

HPV vaccination and screening can help eradicate cervical cancer and other malignancies.

by Anna R. Giuliano, PhD

Imaging tests for post-treatment surveillance may come with radiation exposure, financial strain, “scanxiety” and sometimes unnecessary follow-ups. Doctors and patients need to balance the risks and benefits of scanning.

by Charlotte Huff

Precision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.

by Kendall K. Morgan

Patient-reported outcomes may help shape the future of cancer care.

by Stephen Ornes